论文部分内容阅读
目的 探讨卡前列素氨丁三醇治疗产后出血高危因素产妇的临床疗效和可行性.方法 选取2014年1月~2015年1月我院收治的86例产后出血高危因素产妇作为研究对象,采用随机数字表法将所选产妇分为研究组和对照组,各43例,研究组剖宫产术后注射卡前列氨丁三醇和缩宫素,对照组剖宫产术后注射缩宫素并舌下含服卡前列甲酯栓.比较两组产妇分娩前后血红蛋白水平、术中、术后2h、术后12h、术后24h出血量和不良反应发生率的差异.结果 产前两组血红蛋白水平比较无统计学差异,产后研究组血红蛋白水平为(103.2±4.3)g/L,高于对照组的(99.7±3.6)g/L(P<0.05);研究组产妇术中出血量为(354.1±47.2)mL,术后2h、术后12h、术后24h出血量分别为(121.0±27.4)mL、(317.9±35.9) mL、(467.6±43.6)mL,均少于对照组(P0.05).结论 卡前列素氨丁三醇治疗产后出血高危因素产妇有利于减少产妇出血,能有效维持术后血红蛋白水平,且不良反应少,值得临床推广使用.“,”Objective To investigate effect and safety of carboprost tromethamine injection for puerperas with postpartum hemorrhage symptom.Methods 86 puerperas with postpartum hemorrhage symptom in our hospital were randomly divided into research group and control group,each were 43 cases.Research group were treated with carboprost tromethamine injection combined with oxytocin.Control group were treated with oxytocininjection combined with carboprost methylate.The hematocrystallin level, blood loss and adverse reaction rate of two groups were compared.Results The hematocrystallin level after delivery of research group was higher than control group(P<0.05). The blood loss during operation and afterdelivery of research group were less than control group(P<0.05).There is no significant difference in adverse reaction rate in two groups(P<0.05).Conclusion Carboprost tromethamine injection combined with oxytocin treatment is effective for puerperas with postpartum hemorrhage symptom. It can keep hematocrystallin level and reduce blood loss during operation as well as after delivery, while it has a low adverse reaction rate. It is worthy of widely used.